Margaret A. Cascieri

9.8k total citations
139 papers, 6.7k citations indexed

About

Margaret A. Cascieri is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Margaret A. Cascieri has authored 139 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 64 papers in Cellular and Molecular Neuroscience and 33 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Margaret A. Cascieri's work include Receptor Mechanisms and Signaling (69 papers), Neuropeptides and Animal Physiology (64 papers) and Growth Hormone and Insulin-like Growth Factors (22 papers). Margaret A. Cascieri is often cited by papers focused on Receptor Mechanisms and Signaling (69 papers), Neuropeptides and Animal Physiology (64 papers) and Growth Hormone and Insulin-like Growth Factors (22 papers). Margaret A. Cascieri collaborates with scholars based in United States, United Kingdom and Australia. Margaret A. Cascieri's co-authors include Marvin Bayne, Gary G. Chicchi, Catherine D. Strader, Tehming Liang, Sharon Sadowski, Christopher J. Swain, Tung M. Fong, Joy Applebaum, Nancy S. Hayes and Mari R. Candelore and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Margaret A. Cascieri

139 papers receiving 6.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margaret A. Cascieri United States	47	4.0k	2.3k	1.5k	1.1k	904	139	6.7k
Hans Bräuner‐Osborne Denmark	51	5.6k 1.4×	4.0k 1.7×	898 0.6×	965 0.9×	793 0.9×	231	8.7k
Evi Kostenis Germany	56	6.3k 1.6×	3.5k 1.5×	953 0.6×	345 0.3×	1.3k 1.4×	195	9.7k
Sharron H. Francis United States	52	6.7k 1.7×	815 0.3×	936 0.6×	1.1k 1.0×	2.4k 2.7×	128	9.8k
Theodore W. Rall United States	28	3.7k 0.9×	1.6k 0.7×	869 0.6×	354 0.3×	1.4k 1.5×	49	6.8k
Henry M. Sarau United States	45	3.0k 0.7×	1.8k 0.8×	286 0.2×	559 0.5×	1.5k 1.6×	131	7.5k
Chizuko Yanaihara Japan	36	2.1k 0.5×	2.2k 0.9×	589 0.4×	542 0.5×	453 0.5×	276	4.8k
Robert W. Ledeen United States	52	7.0k 1.7×	1.7k 0.7×	497 0.3×	972 0.9×	2.0k 2.2×	168	9.2k
Marvin C. Gershengorn United States	54	4.7k 1.2×	2.7k 1.2×	3.7k 2.4×	194 0.2×	794 0.9×	251	9.9k
Kevin Beaumont United States	36	2.3k 0.6×	1.5k 0.7×	593 0.4×	422 0.4×	683 0.8×	103	5.0k
Mats Carlquist Sweden	33	4.3k 1.1×	3.4k 1.4×	1.1k 0.7×	422 0.4×	400 0.4×	76	8.4k

Countries citing papers authored by Margaret A. Cascieri

Since Specialization

Citations

This map shows the geographic impact of Margaret A. Cascieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret A. Cascieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret A. Cascieri more than expected).

Fields of papers citing papers by Margaret A. Cascieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret A. Cascieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret A. Cascieri. The network helps show where Margaret A. Cascieri may publish in the future.

Co-authorship network of co-authors of Margaret A. Cascieri

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret A. Cascieri. A scholar is included among the top collaborators of Margaret A. Cascieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret A. Cascieri. Margaret A. Cascieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Lihu, Gabor Butora, Changyou Zhou, et al.. (2007). Discovery of 3-Piperidinyl-1-cyclopentanecarboxamide as a Novel Scaffold for Highly Potent CC Chemokine Receptor 2 Antagonists. Journal of Medicinal Chemistry. 50(11). 2609–2611. 24 indexed citations

Yang, Lihu, Changyou Zhou, Liangqin Guo, et al.. (2006). Discovery of 3,5-bis(trifluoromethyl)benzyl l-arylglycinamide based potent CCR2 antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3735–3739. 20 indexed citations

Butora, Gabor, Gregori J. Morriello, Alexander Pasternak, et al.. (2006). 4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties. Bioorganic & Medicinal Chemistry Letters. 16(18). 4715–4722. 30 indexed citations

Biftu, Tesfaye, Mari R. Candelore, Margaret A. Cascieri, et al.. (2000). Discovery of an orally bioavailable alkyl oxadiazole β3 adrenergic receptor agonist. Bioorganic & Medicinal Chemistry Letters. 10(13). 1427–1429. 15 indexed citations

Parmee, Emma R., Linda Brockunier, Jiafang He, et al.. (2000). Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human β3 adrenergic receptor agonists. Bioorganic & Medicinal Chemistry Letters. 10(20). 2283–2286. 12 indexed citations

Candelore, Mari R., Liping Deng, Laurie Tota, et al.. (1999). Potent and selective human beta(3)-adrenergic receptor antagonists.. PubMed. 290(2). 649–55. 112 indexed citations

Kelly, Linda, Pasquale P. Vicario, G M Thompson, et al.. (1998). Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression. Endocrinology. 139(12). 4920–4927. 245 indexed citations

Cascieri, Margaret A., Elżbieta Ber, Tung M. Fong, et al.. (1997). Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist. European Journal of Pharmacology. 325(2-3). 253–261. 8 indexed citations

Tattersall, F.D., Wayne Rycroft, B. Francis, et al.. (1996). Tachykinin NK1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology. 35(8). 1121–1129. 189 indexed citations

10.

Candelore, Mari R., Liping Deng, Laurie Tota, et al.. (1996). Pharmacological characterization of a recently described human beta 3-adrenergic receptor mutant.. Endocrinology. 137(6). 2638–2641. 79 indexed citations

11.

Hirschmann, Ralph, Wenqing Yao, Margaret A. Cascieri, et al.. (1996). Synthesis of Potent Cyclic Hexapeptide NK-1 Antagonists. Use of a Minilibrary in Transforming a Peptidal Somatostatin Receptor Ligand into an NK-1 Receptor Ligand via a Polyvalent Peptidomimetic. Journal of Medicinal Chemistry. 39(13). 2441–2448. 46 indexed citations

12.

Teall, Martin, Timothy Harrison, Jonathan D. Moseley, et al.. (1996). Linear amides as substance P antagonists. Bioorganic & Medicinal Chemistry Letters. 6(13). 1585–1588. 4 indexed citations

13.

MacLeod, Angus M., Kevin J. Merchant, Frederick A. Brookfield, et al.. (1994). Identification of L-Tryptophan Derivatives with Potent and Selective Antagonist Activity at the NK1 Receptor. Journal of Medicinal Chemistry. 37(9). 1269–1274. 52 indexed citations

14.

Sadowski, Sharon, R R Huang, Tung M. Fong, O. Marko, & Margaret A. Cascieri. (1993). Characterization of the binding of [125I-iodo-histidyl,methyl-Phe7] neurokinin B to the neurokinin-3 receptor. Neuropeptides. 24(6). 317–319. 28 indexed citations

15.

Goh, J. W., Michael E. Kelly, Peter Pennefather, et al.. (1992). Effect of charybdotoxin and leiurotoxon I on potassium currents in bullfrog sympathetic ganglion and hippocampal neurons. Brain Research. 591(1). 165–170. 13 indexed citations

16.

Cascieri, Margaret A., Gary G. Chicchi, & Marvin Bayne. (1991). Characterization of the Biological Activity of IGF I Analogs with Reduced Affinity for IGF Receptors and Binding Proteins. Advances in experimental medicine and biology. 293. 23–30. 6 indexed citations

17.

Cascieri, Margaret A., et al.. (1989). Structural Analogs of Human Insulin-like Growth Factor (IGF) I with Altered Affinity for Type 2 IGF Receptors. Journal of Biological Chemistry. 264(4). 2199–2202. 62 indexed citations

18.

Chicchi, Gary G., Guillermo Giménez‐Gallego, E Ber, et al.. (1988). Purification and characterization of a unique, potent inhibitor of apamin binding from Leiurus quinquestriatus hebraeus venom.. Journal of Biological Chemistry. 263(21). 10192–10197. 110 indexed citations

19.

Rothman, Richard B., Janine A. Danks, Miles Herkenham, et al.. (1984). Autoradiographic localization of a novel peptide binding site in rat brain using the substance P analog, eledoisin. Neuropeptides. 4(4). 343–349. 28 indexed citations

20.

Cascieri, Margaret A., Herbert G. Bull, Richard A. Mumford, et al.. (1984). Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.. Molecular Pharmacology. 25(2). 287–293. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact